» Articles » PMID: 3597522

Antitumor Effect of I.p. Dopamine in Mice Bearing Ehrlich Ascites Carcinoma

Overview
Specialty Oncology
Date 1987 Jan 1
PMID 3597522
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The cancer chemotherapeutic efficacy of dopamine (DA) was evaluated in female strain A mice bearing transplantable Ehrlich ascites carcinoma. The results demonstrated significant inhibition of tumor growth with appreciable increase in the host survival time following DA treatment. Diminished activity of the growth-related respiratory enzyme succinate dehydrogenase along with stimulated activity of the lysosomal enzyme, beta-glucuronidase in DA-treated tumor cells indicated inhibition of tumor growth as well as active lysis of the tumor cells. The direct effect of this compound on tumor proliferation was demonstrated by marked inhibition of DNA synthesis. RNA synthesis was only marginally inhibited.

Citing Articles

Synthesis and Characterization of 3-(1-((3,4-Dihydroxyphenethyl)amino)ethylidene)-chroman-2,4-dione as a Potential Antitumor Agent.

Dimic D, Markovic Z, Saso L, Avdovic E, dorovic J, Petrovic I Oxid Med Cell Longev. 2019; 2019:2069250.

PMID: 30906500 PMC: 6393868. DOI: 10.1155/2019/2069250.


Potential Roles of Peripheral Dopamine in Tumor Immunity.

Zhang X, Liu Q, Liao Q, Zhao Y J Cancer. 2017; 8(15):2966-2973.

PMID: 28928888 PMC: 5604448. DOI: 10.7150/jca.20850.


Immunomodulatory Effects Mediated by Dopamine.

Arreola R, Alvarez-Herrera S, Perez-Sanchez G, Becerril-Villanueva E, Cruz-Fuentes C, Flores-Gutierrez E J Immunol Res. 2016; 2016:3160486.

PMID: 27795960 PMC: 5067323. DOI: 10.1155/2016/3160486.


Role of dopamine in malignant tumor growth.

Basu S, Dasgupta P Endocrine. 2000; 12(3):237-41.

PMID: 10963043 DOI: 10.1385/ENDO:12:3:237.


Alteration of dopamine D2 receptors in human malignant stomach tissue.

Basu S, Dasgupta P Dig Dis Sci. 1997; 42(6):1260-4.

PMID: 9201092 DOI: 10.1023/a:1018862309440.

References
1.
Wick M . Dopamine: a novel antitumor agent active against B-16 melanoma in vivo. J Invest Dermatol. 1978; 71(2):163-4. DOI: 10.1111/1523-1747.ep12546959.1. View

2.
KNOCK F, GALT R, OESTER Y, Sylvester R . Inhibition of DNA polymerases and neoplastic cells by selected SH inhibitors. Oncology. 1972; 26(6):515-28. DOI: 10.1159/000224706. View

3.
Abe I, Sato S . Beta-glucuronidase activity of Yoshida ascites hepatomas of different drug-sensitivity and its change after treatment of host rats with various anticancer agents. Gan. 1976; 67(1):55-65. View

4.
NACHLAS M, TSOU K, De Souza E, Cheng C, Seligman A . Cytochemical demonstration of succinic dehydrogenase by the use of a new p-nitrophenyl substituted ditetrazole. J Histochem Cytochem. 1957; 5(4):420-36. DOI: 10.1177/5.4.420. View

5.
Wick M . Levodopa and dopamine analogs: melanin precursors as antitumor agents in experimental human and murine leukemia. Cancer Treat Rep. 1979; 63(6):991-7. View